Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial

Clinical trial registration, sponsored by University Health Network, Toronto, registered 15 Sep 2026.

Phase 2 · not yet recruiting · n = 46

Tags: Registry, Psilocybin, Cancer.

Weekly Science Digest, 12 Sep 2026 to 18 Sep 2026, finding 6: In the clinic

Newly registered RCT of psilocybin with existential-attachment therapy in advanced cancer, 25 mg versus 1 mg, at UHN Toronto

How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)

Read the original

—
Node—
Statuslive
Throughput—